Comparative evaluation of the Bio-Rad Geenius HIV-1/2 Confirmatory Assay and the Bio-Rad Multispot HIV-1/2 Rapid Test as an alternative differentiation assay for CLSI M53 algorithm-I

Journal of Clinical Virology

Volumn 58, Issue SUPPL1, 2013, Pages

  Malloch, L ^a   Kadivar, K ^a   Putz, J ^b   Levett, P N ^b   Tang, J ^c   Hatchette, T F ^d   Kadkhoda, K ^e   Ng, D ^a   Ho, J ^a   Kim, J ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b Saskatchewan Disease Control Laboratory   (Canada)

^c Alberta Provincial Public Health Laboratory   (Canada)

^d Capital District Health Authority   (Canada)

^e CADHAM PROVINCIAL LABORATORY   (Canada)

Author keywords

Algorithm; Geenius; HIV 1; HIV 2; M53; Multispot

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ALGORITHM; ARTICLE; ENZYME IMMUNOASSAY; HIV 1/2 CONFIRMATORY ASSAY; HIV 1/2 RAPID TEST; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; IMMUNOLOGY TEST KIT; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

AB; AG; ALGORITHM; ANTIBODY; ANTIGEN; APHL; ASSOCIATION OF PUBLIC HEALTH LABORATORIES; CDC; CE; CENTERS FOR DISEASE CONTROL AND PREVENTION; CI; CIRCULATING RECOMBINANT FORM; CLINICAL AND LABORATORY STANDARDS INSTITUTE; CLSI; CONFIDENCE INTERVAL; CONTROL; CRF; CTRL; DEOXYRIBONUCLEIC ACID; DNA; DPP; DUAL PATH PLATFORM; EIA; ENZYME IMMUNOASSAY; EUROPEAN CONFORMITY; FDA; FOOD AND DRUG ADMINISTRATION; GEENIUS; GENETIC SYSTEMS; GLYCOPROTEIN; GP; GS; HIV; HIV-1; HIV-2; HUMAN IMMUNODEFICIENCY VIRUS; IFA; IMMUNOFLUORESCENCE ASSAY; IND; INDETERMINATE; INNO-LIA; INNO-LIA HIV I/II SCORE; K; KAPPA; M53; MULTISPOT; N/A; NAT; NATIONAL LABORATORY FOR HIV REFERENCE SERVICES; NEG; NEGATIVE; NEGATIVE PREDICTIVE VALUE; NLHRS; NOT APPLICABLE; NPV; NUCLEIC ACID TESTING; P; PCR; PCS; POLYMERASE CHAIN REACTION; POS; POSITIVE; POSITIVE PREDICTIVE VALUE; PPV; PROCEDURAL CONTROL SPOT; PROTEIN; R-GP; RECOMBINANT GLYCOPROTEIN; RIBONUCLEIC ACID; RNA; SASKATCHEWAN; SK; SP; SYNTHETIC PEPTIDE; UNT; UNTYPEABLE; W; WB; WEIGHTED FOR PREVALENCE; WESTERN BLOT;

ALGORITHMS; CLINICAL LABORATORY TECHNIQUES; DIAGNOSTIC TESTS, ROUTINE; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; IMMUNOASSAY; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; VIROLOGY;

EID: 84890167971     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.08.008     Document Type: Article

References (16)

1. CDC Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR Morb Mortal Wkly Rep 1989, 38(S-7):1-7.
2. Branson B.M. The future of HIV testing. J Acquired Immune Defici Syndr 2010, 55(Suppl. 2):S102-S105.
3. Clinical and Laboratory Standards Institute (CLSI) Criteria for Laboratory Testing and Diagnosis of Human Immunodeficiency Virus Infection; Approved Guideline. CLSI document M53-A (ISBN 1-56238-757-X [Print]; ISBN 1-56238-758-8 [Electronic]) 2011.
4. United States Patent #7,189,522 B2 Esfandiari J, Chembio Diagnostic Systems, March 13; 2007.
5. Evaluation of diagnostic tests for infectious diseases: general principles. The TDR Diagnostic Evaluation Expert Panel. United Nations. Nat Rev Microbiol 2010, 8(December 12 Suppl):S17-S29.
6. Bio-Rad Geenius HIV 1/2 Confirmatory Assay Kit Insert, 883601-2012/07.
7. Bio-Rad Multispot HIV-1/HIV-2 Rapid Test Kit Insert, 506257-2008/12.
8. Bentsen C., Minard F., Ferret M., Jego J.M., Chaumat P., Gadelle S., et al. HIV 1/2 supplemental assay-Internal performance evaluation. (Poster). National Summit on HIV and Viral Hepatatitis Diagnosis, Prevention and Access to Care 2012.
9. Bentsen C., Minard F., Guerrier L., Gadelle S., Chaumat P., Ferret M., et al. Evaluation of Geenius HIV 1/2 supplemental assay-CE. (Poster). 29th Clinical Virology Symposium 2013.
10. Nasrullah M., Ethridge S.F., Delaney K.P., Wesolowski L.G., Granade T.C., Schwendemann J., et al. Comparison of alternative interpretive criteria for the HIV-1 Western blot and results of the Multispot HIV-1/HIV-2 Rapid test for classifying HIV-1 and HIV-2 infections. J Clin Virol 2011, 52(1):S23-S27.
11. Torian L.V., Forgione L.A., Punsalang P.A., Pirillo R.E., Oleszko W.R. Comparison of Multispot EIA with Western blot for confirmatory diagnosis of HIV. J Clin Virol 2011, 52(December (Suppl.)):S41-S44.
12. Torian L.V., Selik R.M., Branson B., Owen M., Granade T., Shouse L., et al. HIV-2 Infection Surveillance-United States, 1987-2009 Div of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. CDC Morb Mortality Wkly Rep (MMWR) 2011, 60(29):985-988.
13. Masciotra S., McDougal J.S., Feldman J., Sprinkle P., Wesolowski L., Owen S.M. Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections. J Clin Virol 2011, 52S:S17-S22.
14. Styer L.M., Sullivan T.J., Parker M.M. Evaluation of an alternative supplemental testing strategy for HIV diagnosis by retrospective analysis of clinical HIV testing data. J Clin Virol 2011, 52S:S35-S40.
15. Association of Public Health Laboratories (APHL) HIV Diagnostics Survey: Issues in Brief 2012, 1-12.
16. Hutchinson A., Ethridge S., Wesolowski L., Farnham P., Shrestha R., Patel P., et al. Cost and effects of the APHL/CDC proposed laboratory-based algorithm for the detection of HIV. Oral presentation. HIV Diagnostics Conference 2012.